RADIOLOGICAL FINDINGS OF THORACIC INVOLVEMENT IN DERMATOLOGIC DISEASES: WHAT DERMATOLOGISTS SHOULD KNOW
DOI:
https://doi.org/10.29176/2590843X.1552Keywords:
Connective tissue diseases, Connective tissue diseases Interstitial lung diseases, Multidetector computed tomography, Skin diseasesAbstract
There is a great relationship between dermatological diseases and their thoracic manifestations. Its early detection is important, not only to guide the diagnosis with its consequent correlation with skin manifestations, but also to help direct the most appropriate clinical management, such as interstitial lung disease associated with connective tissue pathologies. Within this article there is a review in relation to the clinical and radiological correlation of the main entities both infectious, inflammatory, connective tissue diseases, hereditary and acquired diseases. In addition, this article provides evidence of the importance of performing a multidetector computed tomography in the detection of pulmonary parenchymal pathology that may go unnoticed in the chest radiograph. Explanation of basic radiological terminology is also provided, key to understanding thoracic involvement for the dermatologist.
Author Biographies
Felipe Aluja-Jaramillo
Departamento de Radiología, Hospital Universitario San Ignacio-Pontificia Universidad Javeriana, Country Scan LTDA, Bogotá, Colombia
Jairo Mahecha
Pontificia Universidad Javeriana, Bogotá, Colombia.
Cesar González-Ardila
Médico Dermatólogo, Bogotá, Colombia
References
1. Aluja-Jaramillo F, Acosta L, Gutiérrez FR. Neumonitis por hipersensibilidad y enfermedades del tejido conectivo. En: Avances en diagnóstico por imágenes: Tórax 2. Criales-Cortes JL, Gutiérrez FR. 2.a edición. Buenos Aires, Argentina: Ediciones Journal; 2019. p. 29-43.
2. Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12(4):213. doi: 10.1186/ar3097
3. Kim DS, Yoo B, Lee JS, Kim EK, Lim C, Lee S, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):121-7. PMID: 12108451
4. De Lauretis A, Veeraraghavan S, Renzoni E. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758
5. Kang EH, Lee EB, Shin KC, Im C, Chung D, Han S, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005;44(10):1282-6. doi: 10.1093/rheumatology/keh723
6. Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004,232(1):81-91. doi: 10.1148/radiol.2321030174
7. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-8. doi: 10.1164/rccm.200403-417OC
8. Kanne JP, Yandow DR, Haemel AK, Mayer CA. Beyond skin deep: Thoracic manifestations of systemic disorders affecting the skin. Radiographics. 2011;31(6):1651-68. doi: 10.1148/rg.316115516
9. Fortman BJ, Kuszyk BS, Urban BA, Fishman EK. Neurofibromatosis Type 1: A Diagnostic Mimicker at CT. RadioGraphics. 2001;21(3):601-12. doi: 10.1148/radiographics.21.3. g01ma05601
10. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. The Lancet. 2008;372(9639):657-68. doi: 10.1016/s0140-6736(08)61279-9
11. Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med. 2002;96(1):1-6. doi: 10.1053/rmed.2001.1207
12. Ferrans VJ, Yu ZX, Nelson WK, Valencia JC, Tatsuguchi A, Avila NA, et al. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J Nippon Med Sch. 2000;67(5):311-29. doi: 10.1272/jnms.67.311
13. Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, et al. Comprehensive Evaluation of 35 Patients with Lymphangioleiomyomatosis. Chest. 1999;115(4):1041-52. doi: 10.1378/chest.115.4.1041
14. Nakatsu M, Hatabu H, Morikawa K, Uematsu H, Ohno Y, Nishimura K, t al. Large coalescent parenchymal nodules in pulmonary sarcoidosis: “sarcoid galaxy” sign. AJR Am J Roentgenol. 2002;178(6):1389-93. doi: 10.2214/ajr.178.6.1781389
15. Reddy GP, Ahuja JP. Thoracic Sarcoidosis: Imaging Patterns. Semin Roentgenol. 2019;54(1):59-65. doi: 10.1053/j.ro.2018.12.008
16. Aluja-Jaramillo F, Gutiérrez FR, Rossi S, Bhalla S. Nonneoplastic Tracheal Abnormalities on CT. CDR. 2020;43(13):7-8. doi: 10.1097/01.CDR.0000668644.62958.46
17. Massey H, Darby M, Edey A. Thoracic complications of rheumatoid disease. Clin Radiol. 2013;68(3):293-301. doi: 10.1016/j.crad.2012.07.007
18. Turesson C, Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extraarticular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722-7. doi: 10.1136/ard.62.8.722
19. Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmun Rev. 2011;11(2):123-31. doi: 10.1016/j.autrev.2011.09.001
20. Copobianco J, Grimberg A, Thompson BM, Antunes VB, Jasinowodolinski D, Meirelles GS. Thoracic manifestations of collagen vascular diseases. Radiographics. 2012;32(1):33-50. doi: 10.1148/rg.321105058
21. Franquet T. High-resolution ct of lung disease related to collagen vascular disease. Radiol Clin N Am. 2001;39(6):1171-87. doi: 10.1016/s0033-8389(05)70337-7
22. Lieberman-Maran L, Orzano IM, Passero MA, Lally EV. Bronchiectasis in Rheumatoid Arthritis: Report of Four Cases and a Review of the Literature Implications for Management with Biologic Response Modifiers. Semin Arthritis Rheum. 2006;35(6):379-87. doi: 10.1016/j.semarthrit.2006.02.003
23. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations. RadioGraphics. 2000;20(5):1245-59. doi: 10.1148/radiographics.20.5.g00se081245
24. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists. Clin Infect Dis. 2004;38(9):1261-5. doi: 10.1086/383317
25. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start antiTNF-alpha treatment. Thorax. 2005;60(10):800-5. doi: 10.1136/thx.2005.046797
26. Dalakas MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol. 2010;10(3):346-52. doi: 10.1016/j.coph.2010.03.001
27. Hallowell R, Ascherman D, Danoff S. Pulmonary Manifestations of Polymyositis/Dermatomyositis. Semin Respir Crit Care Med. 2014;35(2):239-48. doi: 10.1055/s-0034-1371528
28. Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest. 1987;91(1):118-27. doi: 10.1378/chest.91.1.118
29. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010;37(1):42-53. doi: 10.1111/j.1346-8138.2009.00762.x
30. Stojan G, Baer AN, Danoff SK. Pulmonary manifestations of Sjögren's syndrome. Curr Allergy Asthma Rep. 2013;13(4):354-60. doi: 10.1007/s11882-013-0357-9
31. Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19(9):1050-70. doi: 10.1177/0961203310370048
32. Goh YP, Naidoo P, Ngian GS. Imaging of systemic lupus erythematosus. Part I: CNS, cardiovascular, and thoracic manifestations. Clin Radiol. 2013;68(2):181-91. doi: 10.1016/j.crad.2012.06.110
33. Paran D, Fireman E, Elkayam O. Pulmonary disease in systemic lupus erythematosus and the antiphospholipid syndrome. Autoimmun Rev. 2004;3(1):70-5. doi: 10.1016/S1568-9972(03)00090-9
34. Yeung H, Takeshita J, Mehta N, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidities: a population-based study. JAMA Dermatol. 2013;149(10):1173-9. doi: 10.1001/jamadermatol.2013.5015
35. Wu CY, Hu HY, Li CP, Chou YJ, Chang YT. Comorbidity profiles of psoriasis in Taiwan: A latent class analysis. PLoS ONE. 2018;13(2):e0192537. doi: 10.1371/journal.pone.0192537
36. Balsi DD, Celik E, Genc S, Celik MM, Inan MU. Impaired Pulmonary Function in Patients with Psoriasis. Dermatology. 2006;232(6):664-7. doi: 10.1159/000456032
37. Londoño A, González C, Castro L, Puig L. Psoriasis y su relación con el síndrome metabólico. Rev Colomb Reumatol. 2013;20(4):228-36.
38. Chiang H, Lin H. Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2012;26(1):59-65. doi: 10.1111/j.1468-3083.2011.04009.x
39. Ungprasert P, Srivali N, Thongprayoon C. Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis. J Dermatolog Treat. 2016;27(4):316-21. doi: 10.3109/09546634.2015.1107180
40. Choi Y, Shannon F, Wu J. Incidence of Pulmonary Arterial Hypertension in Patients with Psoriasis: A Retrospective Cohort Study. Perm J. 2017;21:16-073. doi: 10.7812/TPP/16-073
41. Wanat K, Schaffer A, Richardson V, VanVoorhees A, Rosenbach M. Sarcoidosis and Psoriasis A Case Series and Review of the Literature Exploring Co-Incidence vs Coincidence. JAMA Dermatol. 2013;149(7):848-52. doi: 10.1001/jamadermatol.2013.4256
42. Khalid U, Hilmar GH, Hansen PR. Sarcoidosis in Patients with Psoriasis: A Population- Based Cohort Study. PLoS ONE. 2014;9(10):e109632. doi: 10.1371/journal.pone.0109632
43. Restrepo CS, Martínez S, Lemos JA, Carrillo JA, Lemos DF, Ojeda P, et al. Imaging Manifestations of Kaposi Sarcoma. RadioGraphics. 2006;26(4):1169-85. doi: 10.1148/rg.264055129
44. Willatt HJ, Moyano NC, Apey RC, Lidid AL. Sarcoma de Kaposi extratorácico: evidencias de una enfermedad multisistémica. Rev Chil Radiol. 2010;16(2):80-5. doi: 10.4067/S0717-93082010000200008
45. Wolff SD, Kuhlman JE, Fishman EK. Thoracic Kaposi sarcoma in AIDS: CT findings. J Comput Assist Tomogr. 1993;17(1):60-2. doi: 10.1097/00004728-199301000-00010
46. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-73. doi: 10.1001/archinternmed.2008.603
47. Dodd JD, Souza CA, Müller NL. High-Resolution MDCT of Pulmonary Septic Embolism: Evaluation of the Feeding Vessel Sign. AJR Am J Roentgenol. 2006;187(3):623-9. doi: 10.2214/AJR.05.0681
48. Depasquale R, Kumar N, Lalam RK, Tins BJ, Tyrrell PNM, Singh J, et al. SAPHO: What radiologists should know. Clin Radiol. 2012;67(3):195-206. doi: 10.1016/j.crad.2011.08.014
49. Lew PP, Ngai SS, Hamidi R, Cho JK, Birnbaum RA, Peng DH, et al. Imaging of Disorders Affecting the Bone and Skin. RadioGraphics. 2014;34(1):197-216. doi: 10.1148/rg.341125112
2. Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12(4):213. doi: 10.1186/ar3097
3. Kim DS, Yoo B, Lee JS, Kim EK, Lim C, Lee S, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):121-7. PMID: 12108451
4. De Lauretis A, Veeraraghavan S, Renzoni E. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758
5. Kang EH, Lee EB, Shin KC, Im C, Chung D, Han S, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005;44(10):1282-6. doi: 10.1093/rheumatology/keh723
6. Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004,232(1):81-91. doi: 10.1148/radiol.2321030174
7. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-8. doi: 10.1164/rccm.200403-417OC
8. Kanne JP, Yandow DR, Haemel AK, Mayer CA. Beyond skin deep: Thoracic manifestations of systemic disorders affecting the skin. Radiographics. 2011;31(6):1651-68. doi: 10.1148/rg.316115516
9. Fortman BJ, Kuszyk BS, Urban BA, Fishman EK. Neurofibromatosis Type 1: A Diagnostic Mimicker at CT. RadioGraphics. 2001;21(3):601-12. doi: 10.1148/radiographics.21.3. g01ma05601
10. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. The Lancet. 2008;372(9639):657-68. doi: 10.1016/s0140-6736(08)61279-9
11. Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med. 2002;96(1):1-6. doi: 10.1053/rmed.2001.1207
12. Ferrans VJ, Yu ZX, Nelson WK, Valencia JC, Tatsuguchi A, Avila NA, et al. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J Nippon Med Sch. 2000;67(5):311-29. doi: 10.1272/jnms.67.311
13. Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, et al. Comprehensive Evaluation of 35 Patients with Lymphangioleiomyomatosis. Chest. 1999;115(4):1041-52. doi: 10.1378/chest.115.4.1041
14. Nakatsu M, Hatabu H, Morikawa K, Uematsu H, Ohno Y, Nishimura K, t al. Large coalescent parenchymal nodules in pulmonary sarcoidosis: “sarcoid galaxy” sign. AJR Am J Roentgenol. 2002;178(6):1389-93. doi: 10.2214/ajr.178.6.1781389
15. Reddy GP, Ahuja JP. Thoracic Sarcoidosis: Imaging Patterns. Semin Roentgenol. 2019;54(1):59-65. doi: 10.1053/j.ro.2018.12.008
16. Aluja-Jaramillo F, Gutiérrez FR, Rossi S, Bhalla S. Nonneoplastic Tracheal Abnormalities on CT. CDR. 2020;43(13):7-8. doi: 10.1097/01.CDR.0000668644.62958.46
17. Massey H, Darby M, Edey A. Thoracic complications of rheumatoid disease. Clin Radiol. 2013;68(3):293-301. doi: 10.1016/j.crad.2012.07.007
18. Turesson C, Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extraarticular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722-7. doi: 10.1136/ard.62.8.722
19. Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmun Rev. 2011;11(2):123-31. doi: 10.1016/j.autrev.2011.09.001
20. Copobianco J, Grimberg A, Thompson BM, Antunes VB, Jasinowodolinski D, Meirelles GS. Thoracic manifestations of collagen vascular diseases. Radiographics. 2012;32(1):33-50. doi: 10.1148/rg.321105058
21. Franquet T. High-resolution ct of lung disease related to collagen vascular disease. Radiol Clin N Am. 2001;39(6):1171-87. doi: 10.1016/s0033-8389(05)70337-7
22. Lieberman-Maran L, Orzano IM, Passero MA, Lally EV. Bronchiectasis in Rheumatoid Arthritis: Report of Four Cases and a Review of the Literature Implications for Management with Biologic Response Modifiers. Semin Arthritis Rheum. 2006;35(6):379-87. doi: 10.1016/j.semarthrit.2006.02.003
23. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations. RadioGraphics. 2000;20(5):1245-59. doi: 10.1148/radiographics.20.5.g00se081245
24. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists. Clin Infect Dis. 2004;38(9):1261-5. doi: 10.1086/383317
25. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start antiTNF-alpha treatment. Thorax. 2005;60(10):800-5. doi: 10.1136/thx.2005.046797
26. Dalakas MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol. 2010;10(3):346-52. doi: 10.1016/j.coph.2010.03.001
27. Hallowell R, Ascherman D, Danoff S. Pulmonary Manifestations of Polymyositis/Dermatomyositis. Semin Respir Crit Care Med. 2014;35(2):239-48. doi: 10.1055/s-0034-1371528
28. Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest. 1987;91(1):118-27. doi: 10.1378/chest.91.1.118
29. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010;37(1):42-53. doi: 10.1111/j.1346-8138.2009.00762.x
30. Stojan G, Baer AN, Danoff SK. Pulmonary manifestations of Sjögren's syndrome. Curr Allergy Asthma Rep. 2013;13(4):354-60. doi: 10.1007/s11882-013-0357-9
31. Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19(9):1050-70. doi: 10.1177/0961203310370048
32. Goh YP, Naidoo P, Ngian GS. Imaging of systemic lupus erythematosus. Part I: CNS, cardiovascular, and thoracic manifestations. Clin Radiol. 2013;68(2):181-91. doi: 10.1016/j.crad.2012.06.110
33. Paran D, Fireman E, Elkayam O. Pulmonary disease in systemic lupus erythematosus and the antiphospholipid syndrome. Autoimmun Rev. 2004;3(1):70-5. doi: 10.1016/S1568-9972(03)00090-9
34. Yeung H, Takeshita J, Mehta N, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidities: a population-based study. JAMA Dermatol. 2013;149(10):1173-9. doi: 10.1001/jamadermatol.2013.5015
35. Wu CY, Hu HY, Li CP, Chou YJ, Chang YT. Comorbidity profiles of psoriasis in Taiwan: A latent class analysis. PLoS ONE. 2018;13(2):e0192537. doi: 10.1371/journal.pone.0192537
36. Balsi DD, Celik E, Genc S, Celik MM, Inan MU. Impaired Pulmonary Function in Patients with Psoriasis. Dermatology. 2006;232(6):664-7. doi: 10.1159/000456032
37. Londoño A, González C, Castro L, Puig L. Psoriasis y su relación con el síndrome metabólico. Rev Colomb Reumatol. 2013;20(4):228-36.
38. Chiang H, Lin H. Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2012;26(1):59-65. doi: 10.1111/j.1468-3083.2011.04009.x
39. Ungprasert P, Srivali N, Thongprayoon C. Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis. J Dermatolog Treat. 2016;27(4):316-21. doi: 10.3109/09546634.2015.1107180
40. Choi Y, Shannon F, Wu J. Incidence of Pulmonary Arterial Hypertension in Patients with Psoriasis: A Retrospective Cohort Study. Perm J. 2017;21:16-073. doi: 10.7812/TPP/16-073
41. Wanat K, Schaffer A, Richardson V, VanVoorhees A, Rosenbach M. Sarcoidosis and Psoriasis A Case Series and Review of the Literature Exploring Co-Incidence vs Coincidence. JAMA Dermatol. 2013;149(7):848-52. doi: 10.1001/jamadermatol.2013.4256
42. Khalid U, Hilmar GH, Hansen PR. Sarcoidosis in Patients with Psoriasis: A Population- Based Cohort Study. PLoS ONE. 2014;9(10):e109632. doi: 10.1371/journal.pone.0109632
43. Restrepo CS, Martínez S, Lemos JA, Carrillo JA, Lemos DF, Ojeda P, et al. Imaging Manifestations of Kaposi Sarcoma. RadioGraphics. 2006;26(4):1169-85. doi: 10.1148/rg.264055129
44. Willatt HJ, Moyano NC, Apey RC, Lidid AL. Sarcoma de Kaposi extratorácico: evidencias de una enfermedad multisistémica. Rev Chil Radiol. 2010;16(2):80-5. doi: 10.4067/S0717-93082010000200008
45. Wolff SD, Kuhlman JE, Fishman EK. Thoracic Kaposi sarcoma in AIDS: CT findings. J Comput Assist Tomogr. 1993;17(1):60-2. doi: 10.1097/00004728-199301000-00010
46. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-73. doi: 10.1001/archinternmed.2008.603
47. Dodd JD, Souza CA, Müller NL. High-Resolution MDCT of Pulmonary Septic Embolism: Evaluation of the Feeding Vessel Sign. AJR Am J Roentgenol. 2006;187(3):623-9. doi: 10.2214/AJR.05.0681
48. Depasquale R, Kumar N, Lalam RK, Tins BJ, Tyrrell PNM, Singh J, et al. SAPHO: What radiologists should know. Clin Radiol. 2012;67(3):195-206. doi: 10.1016/j.crad.2011.08.014
49. Lew PP, Ngai SS, Hamidi R, Cho JK, Birnbaum RA, Peng DH, et al. Imaging of Disorders Affecting the Bone and Skin. RadioGraphics. 2014;34(1):197-216. doi: 10.1148/rg.341125112
How to Cite
1.
Aluja-Jaramillo F, Mahecha J, González-Ardila C. RADIOLOGICAL FINDINGS OF THORACIC INVOLVEMENT IN DERMATOLOGIC DISEASES: WHAT DERMATOLOGISTS SHOULD KNOW. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2021 Jan. 25 [cited 2024 Jul. 3];28(4):325-39. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1552
Downloads
Download data is not yet available.
Downloads
Published
2021-01-25
How to Cite
1.
Aluja-Jaramillo F, Mahecha J, González-Ardila C. RADIOLOGICAL FINDINGS OF THORACIC INVOLVEMENT IN DERMATOLOGIC DISEASES: WHAT DERMATOLOGISTS SHOULD KNOW. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2021 Jan. 25 [cited 2024 Jul. 3];28(4):325-39. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1552
Issue
Section
Review Article
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
